CRISPR Therapeutics AG short interest in 2019

In 2019, CRISPR Therapeutics AG's disclosed short interest ran from 9.31% of shares outstanding on 15 Oct 2019 to 6.19% on 31 Dec 2019, a change of -3.12 percentage points. The year's high was 10.07% on 15 Nov 2019 and its low 6.15% on 13 Dec 2019, averaging 7.97% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.15 days on 15 Oct 2019. Full history: CRISPR Therapeutics AG.

Cite this page

Plain

Short position data for CRISPR Therapeutics AG short interest in 2019: FINRA, compiled by howshorted.com, settlement date 31 Dec 2019. https://howshorted.com/us/company/crsp/2019/

Wikipedia

<ref>{{cite web |title=CRISPR Therapeutics AG short interest in 2019 short position data |url=https://howshorted.com/us/company/crsp/2019/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2019-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-crispr-therapeutics-ag-short-interest-in-2019-12-31,
  title        = {CRISPR Therapeutics AG short interest in 2019 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/crsp/2019/}},
  note         = {Data: FINRA, settlement date 31 Dec 2019; accessed 2026-10-13},
  year         = {2019}
}

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2019 in figures

Start of year: 9.31% (15 Oct 2019)
End of year: 6.19% (31 Dec 2019)
Change: -3.12 pp
High: 10.07% (15 Nov 2019)
Low: 6.15% (13 Dec 2019)
Average: 7.97%
Highest days to cover: 8.15 (15 Oct 2019)
SEC filings marked: 8

Every report in 2019

CRISPR Therapeutics AG short interest in 2019
Settlement	Short interest	Days to cover	Filings since previous
15 Oct 2019	9.31%	8.15	10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 2019	9.57%	7.52	10-Q filed, results (8-K)
15 Nov 2019	10.07%	7.30
29 Nov 2019	6.55%	1.51
13 Dec 2019	6.15%	3.05
31 Dec 2019	6.19%	4.07

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.